In recent years, the Graduate School of Biomedical Sciences has reorganized several of its graduate programs. Three programs, Biochemistry, Cell, Molecular & Developmental Biology (CMDB), and Cellular & Molecular Physiology (CMP), chose to merge into one, newly configured CMDB program. In addition, the PhD program in Pharmacology & Experimental Therapeutics (PPET) no longer accepts students.
Students enrolled in these "legacy" programs at the time of the changes remain enrolled in their original programs and are progressing toward their degrees. GSBS is fully committed to supporting these students.